Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.11B |
| 2 |
NVIDIA
NVDA
|
+$2.59B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.58B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.21B |
| 2 |
Lam Research
LRCX
|
+$976M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$771M |
| 4 |
Warner Bros
WBD
|
+$771M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$710M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.73% |
| 2 | Financials | 9.04% |
| 3 | Consumer Discretionary | 7.38% |
| 4 | Healthcare | 7.28% |
| 5 | Industrials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFTX
2001
Definium Therapeutics
DFTX
$5.57B
| $31.7M | ﹤0.01% |
1,675,411
+750,079
| +81% | +$12.7M |
|
2002
PROG Holdings
PRG
$1.81B
| $31.6M | ﹤0.01% |
1,103,081
-721,010
| -40% | -$23.3M |
|
2003
Sable Offshore Corp
SOC
$794M
| $31.6M | ﹤0.01% |
1,915,423
+961,164
| +101% | +$11.2M |
|
2004
CALL
Wayfair
W
$12.5B
| $31.6M | ﹤0.01% |
420,700
-169,900
| -29% | -$15.4M |
|
2005
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.3B
| $31.6M | ﹤0.01% |
632,719
-157,276
| -20% | -$7.94M |
|
2006
PUT
Marathon Petroleum
MPC
$89.3B
| $31.5M | ﹤0.01% |
129,200
-50,000
| -28% | -$10.1M |
|
2007
Freshworks
FRSH
$3.09B
| $31.5M | ﹤0.01% |
3,923,852
+1,096,007
| +39% | +$10.1M |
|
2008
PUT
KE Holdings
BEKE
$17.7B
| $31.4M | ﹤0.01% |
2,100,000
-1,602,400
| -43% | -$27.5M |
|
|
TEM
2009
PUT
Tempus AI
TEM
$7.72B
| $31.4M | ﹤0.01% |
694,200
-553,700
| -44% | -$31.5M |
|
2010
New Jersey Resources
NJR
$6.04B
| $31.4M | ﹤0.01% |
571,475
-67,425
| -11% | -$3.49M |
|
2011
Celldex Therapeutics
CLDX
$2.79B
| $31.4M | ﹤0.01% |
988,416
-79,715
| -7% | -$2.17M |
|
2012
PUT
Coherent
COHR
$47.6B
| $31.3M | ﹤0.01% |
131,400
+106,400
| +426% | +$24.4M |
|
|
UCTT
2013
Ultra Clean Holdings
UCTT
$3.47B
| $31.3M | ﹤0.01% |
503,328
-54,848
| -10% | -$2.81M |
|
2014
Belden
BDC
$4.09B
| $31.3M | ﹤0.01% |
272,241
-90,096
| -25% | -$11.3M |
|
2015
Viking Therapeutics
VKTX
$3.93B
| $31.3M | ﹤0.01% |
960,570
+127,919
| +15% | +$4.11M |
|
2016
Dyne Therapeutics
DYN
$4.28B
| $31.2M | ﹤0.01% |
1,723,116
-560,075
| -25% | -$9.66M |
|
2017
Outfront Media
OUT
$5.72B
| $31.2M | ﹤0.01% |
1,176,761
+145,344
| +14% | +$3.79M |
|
2018
Floor & Decor
FND
$6.14B
| $31.1M | ﹤0.01% |
613,023
+338,353
| +123% | +$22M |
|
2019
Viridian Therapeutics
VRDN
$2.15B
| $31.1M | ﹤0.01% |
1,591,945
+327,898
| +26% | +$9.74M |
|
2020
PUT
Analog Devices
ADI
$178B
| $31.1M | ﹤0.01% |
97,800
+47,800
| +96% | +$15.2M |
|
2021
PUT
Diamondback Energy
FANG
$53.5B
| $31.1M | ﹤0.01% |
157,300
-149,100
| -49% | -$25.3M |
|
2022
Griffon
GFF
$4.29B
| $31.1M | ﹤0.01% |
427,765
+54,850
| +15% | +$4.44M |
|
2023
Freshpet
FRPT
$3.01B
| $31M | ﹤0.01% |
526,617
+295,788
| +128% | +$20.8M |
|
2024
Navitas Semiconductor
NVTS
$2.44B
| $31M | ﹤0.01% |
3,539,753
+2,369,294
| +202% | +$21.8M |
|
2025
Corporacion America
CAAP
$4.26B
| $30.9M | ﹤0.01% |
1,222,796
-49,026
| -4% | -$1.33M |
|
Similar funds
Goldman Sachs's Q1 2026 Portfolio in Review
As of Q1 2026, Goldman Sachs held 7,166 positions worth $871B, up 6.8% from $815B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs deployed $86.3B of net new capital in Q1 2026, opening 752 new positions and adding to 3,118 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $1.21B trimmed.
- Goldman Sachs's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
- Goldman Sachs added most to Microsoft in Q1 2026, an estimated $4.11B increase.
- Goldman Sachs's biggest Q1 2026 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $1.21B.
- Goldman Sachs fully exited Dayforce in Q1 2026, selling an estimated $441M.
- Goldman Sachs's ten largest holdings make up 20% of its $871B portfolio in Q1 2026.
- Goldman Sachs opened 752 new positions and closed 735 in Q1 2026.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $871B.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.